NASDAQ OMX

Quark Extends QuarkXPress Competitive Upgrade Offer: InDesign Users Save over 50%

Dela

Competitive Upgrade Gives Users of Alternative Design Software Even More Reasons to Switch to QuarkXPress 2017

Denver, CO, Oct.  04, 2017  (GLOBE NEWSWIRE) -- Quark announced today that, due to popular demand, the QuarkXPress 2017 Competitive Upgrade offer has been extended until December 31, 2017. For a limited time, InDesign®, Photoshop®, Creative Suite®/Creative Cloud®, CorelDraw®, and Microsoft® Publisher users can save 50% on a license of QuarkXPress 2017, the new version of Quark's fully-integrated graphic design and layout software for professional print and digital production.

Limited Time Offer - Over 50% Discount
Users with an eligible product who want to switch or add QuarkXPress to their workflow can purchase a full new commercial license of QuarkXPress 2017 (Mac/Win) for just $399/€430/£345. The perpetual license is unrestricted and can be upgraded to future versions.

Eligible products include: Adobe InDesign®, Adobe FrameMaker®, Adobe Lightroom®, Adobe PageMaker®, Adobe Photoshop®, Capture One® Pro, CorelDraw®, Microsoft® Publisher and Serif PagePlus®. All versions of qualifying products are accepted including perpetual, rental, and subscription licenses.

To learn more about the competitive upgrade offer please visit: www.quark.com/switch

PLUS: The Competitive Upgrade CAN be combined with the new callas pdfToolbox offer until October 31, 2017, which adds a free license of callas pdfToolbox - worth $590/£459/€499 - to all upgrades of QuarkXPress 2017.

Top 10 Reasons to Switch to QuarkXPress
QuarkXPress 2017 is the alternative for every creative professional who wants to leverage the modern and efficient design software and, if you're an InDesign/Photoshop/CC user, escape the ongoing subscription model with a perpetual license of QuarkXPress. Here are 10 reasons to consider QuarkXPress now:

1. No monthly subscription - designers own their copy of QuarkXPress
2. More intuitive user interface, less palette clutter, and faster time to results
3. Ability to convert any PDF to editable QuarkXPress objects
4. Ability to copy and paste objects from InDesign, Illustrator, and Excel as editable QuarkXPress objects
5. Ability to convert print layouts into interactive HTML5 publications
6. Non-destructive image editing
7. Superior typographic controls for kerning pairs, font tracking tables, and text variables
8. More granular design control for optical margin alignment, gradients, and opacity
9. Ability to output unlimited iOS single apps for free
10. Lower cost of ownership - designers determine when upgrading is right for them

Switch, Upgrade to, or Purchase QuarkXPress 2017
To purchase QuarkXPress 2017, visit the Quark eStore, call Quark Telesales, or find an Authorized Quark Reseller.

# # #

Quark, QuarkXPress, and the Quark logo are trademarks or registered trademarks of Quark Software Inc. and its affiliates in the U.S. and/or other countries.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/742d2fc7-5472-4e4a-ba20-13fa3aa74b59

Sarah Rector
Quark Software Inc.
303-894-3753
srector@quark.com








This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Quark Software Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Banque Fédérative du Credit Mutuel: Post Stabilisation Notice22.1.2018 15:10Pressmeddelande

PARIS, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Banque Fédérative du Credit Mutuel Post Stabilisation Notice HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities. Issuer: Banque Fédérative du Credit Mutuel Guarantor (if any): na Aggregate nominal amount: GBP 450,000,000 Description: 1.375% due Dec 2021 Offer price: 99.872 Stabilising Managers: HSBC & Goldman Sachs This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction This information is provided by RNS The company news service from the London Stock Exchange Contacts: RNS Customer Services 0044-207797-4400 rns@londonstockexchange.com http://www.rns.com This announ

FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers22.1.2018 15:00Pressmeddelande

SAN DIEGO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(K) clearance to market its EZ Vitamin D assay for Clinical Chemistry Analyzers. Diazyme's two reagent EZ Vitamin D assay provides the only fully automated two reagent Vitamin D test for use on validated clinical chemistry analyzers. "Diazyme's EZ Vitamin D assay is a universal fully automated Vitamin D test that is specifically designed for use on clinical chemistry analyzers. This liquid stable, ready-to-use two reagent system measures total 25-hydroxy Vitamin D (25-OH Vitamin D2 + 25-OH Vitamin D3) levels. This assay enables clinical laboratories of almost any size to run Vitamin D test in house without the need for expensive specialized instrumentation. With no sample pre-treatment or pre-dilution steps required, this high-throughput liquid stable assay provides precise test results, is user friendly, cost effective and has excellen

Fura Completes Acquisition of Colombian Emerald Mine, Coscuez22.1.2018 13:00Pressmeddelande

TORONTO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Fura Gems Inc. (TSXV:FURA) is pleased to announce that it has completed its acquisition of 76% of the issued and outstanding shares of Esmeracol S.A. ("Esmeracol"), which owns a 100% interest in mining licence no. 122 - 95M (the "Coscuez Licence"). Dev Shetty, President & CEO of Fura, commented: "Fura has achieved one more important milestone by adding the iconic Colombian emerald mine, Coscuez, to its portfolio. With this acquisition, Fura now has two important silos in its portfolio, Colombian emeralds and Mozambican rubies. Fura will now work towards modernisation of the Coscuez emerald mine and deployment of the best health and safety standards for its employees while keeping the environmental impact minimal. Fura will also closely work with the local community and relevant authorities to promote the social-economic development in the region. We would like to thank our local partner and also the entire team on the ground in the Colombia fo

Agency for the Cooperation of Energy Regulators (ACER) continues to use Nasdaq's SMARTS for Pan-European Market Monitoring of EU Wholesale Energy Markets22.1.2018 12:30Pressmeddelande

NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Agency for the Cooperation of Energy Regulators (ACER) has officially extended its contract with Nasdaq (Nasdaq:NDAQ) to continue to leverage Nasdaq's SMARTS Market Surveillance technology to detect insider trading and market manipulation across the European Union's wholesale energy markets by digesting and analyzing massive volumes of data from hundreds of power producers, exchanges, operators, and brokers across 28 member states. The new agreement contract extension will continue to allow national regulatory authorities to share data, technology, and expertise, with the aim of creating a cooperative regulatory infrastructure. Under the contract, SMARTS technology will continue being leveraged to monitor the European wholesale gas and electricity markets, covering both spot trading and derivative markets across Europe in accordance with the obligations under the REMIT legislation. Further, the surveillance technology will support ACER's

Bell Canada Reaches Milestone in Network 3.0 Vision with Open Network Automation Platform (ONAP) and Strategic Partnership with Amdocs22.1.2018 12:00Pressmeddelande

Bell's leadership in bringing open source ONAP into production enables innovative new offerings to customers faster and at lower cost ST. LOUIS, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced that Bell, Canada's largest communications company, has successfully implemented the first network automation use case in production leveraging the Linux Foundation's Open Network Automation Platform (ONAP). As Bell's strategic partner, Amdocs brings unparalleled ONAP expertise and DevOps scrum team agility and delivery capabilities with the goal of driving innovation faster and reducing the cost of building and operating the data center of the future. With clear benefits such as a more elastic network and increased business agility to be gained from taking advantage of network functions virtualization (NFV), Bell is driving its network transformation by leveraging the ONAP-based network serv

Alvogen CEO Robert Wessman speaks exclusively to World Finance about new opportunities in generic pharmaceuticals22.1.2018 11:51Pressmeddelande

LONDON, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Industry disruptor Robert Wessman, the CEO of rapidly growing generic pharmaceuticals company Alvogen, shares his thoughts on the latest market trends in the new edition of World Finance magazine. Only different in name and price, generic pharmaceuticals in the US are a whopping 50 to 70 percent less expensive than their branded equivalents. Unsurprisingly, in an era of ever-rising medical costs, a growing number of governmental entities and corporations are now choosing generics over branded pharmaceuticals. For some time, just a handful of big-name organisations dominated this nascent market. But, following its peak in 2015, over-valuations have prompted vulnerability, opening the door for new, more nimble competitors to join and disrupt the market. Among this innovative group of 'next generation' pharmaceutical companies is Reykjavik-based Alvogen. Though it was only established in 2009, this global-facing organisation now boasts an annual t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum